DUBAI, United Arab Emirates, Jan. 10, 2023 (GLOBE NEWSWIRE) -- Future Market Insights estimates that the Hyperphosphatemia Market will experience a rapid expansion between the years 2023 and 2033. By ...

New York, March 31, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Hyperphosphatemia Treatment Global Market Report 2023" - https ...

In a landscape where complexity has long been the norm, the power of one lies not just in unification, but in intelligence and automation. Current phosphate management options, including dietary ...

Hypophosphatemia is a condition caused due to a high level of phosphate or phosphorous in the blood. Phosphate is a chemical found in body and contain mineral called phosphorous. Phosphorus mineral is ...

Hyperphosphatemia companies are Shanghai Alebund Pharmaceuticals, Taisho Pharmaceuticals, Kyowa Kirin Korea Co., Ltd., Keryx Biopharmaceuticals and others. (Las Vegas, Nevada, United States) As per ...

FREMONT, Calif., Sept. 3, 2019 /PRNewswire/ -- Ardelyx, Inc. (Nasdaq: ARDX), a specialized biopharmaceutical company focused on developing first-in-class medicines to improve treatment for people with ...

LOS ALTOS, Calif., March 13, 2025 (GLOBE NEWSWIRE) -- Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease, today ...

Hyperphosphatemia Treatment Global Market Report 2022 – Market Size, Trends, And Global Forecast 2022-2026 The Business Research Company's Hyperphosphatemia Treatment Global Market Report 2022 – ...

New York, June 07, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Hyperphosphatemia Treatment Global Market Report 2022" - https://www ...